Form D · Venture Capital Fund
OurCrowd (Investment in Morphisec) LP
Jerusalem, L3 · CIK 0001658184
Offering snapshot reported May 20, 2026 · SEC filing
- Reported sold
- $19.7K Offering amount: $500K
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $10K Reported outside-investor minimum
- First sale
- May 4, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 20, 2026 | Initial | $19,744 | No comparison | 4 | SEC filing |
| Feb 5, 2021 | Initial | $42,800 | No comparison | 5 | SEC filing |
| Dec 1, 2015 | Initial | $1,036,299 | No comparison | 49 | SEC filing |
Offering details
- Securities
- Pooled investment fund
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-584670
Source: Form D, filed May 20, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Steven Blumgart | Director, Executive |
| Caleb Chill | Executive |
| Robert Citron | Executive |
| Jay Kalish | Executive |
| Andrew Kaye | Director, Executive |
| Jonathan Medved | Director, Executive |
Issuer details
Industry: Pooled Investment Fund (See others in industry)
Address:
28 Derech Hebron
Jerusalem, L3, 9108001
Phone: 972-2-636-9300
Jerusalem, L3, 9108001
Phone: 972-2-636-9300